Walleye Trading’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Walleye Trading’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-62,973	Closed	-$838	–	5573
2023 Q2	$838	Hold	62,973	–	–	﹤0.01%	4590
2023 Q1	$3.22K	Hold	62,973	–	–	﹤0.01%	4567
2022 Q4	$5.35K	Hold	62,973	–	–	﹤0.01%	4579
2022 Q3	$14K	Buy	62,973 +9,864	+19%	+$3K	﹤0.01%	4488
2022 Q2	$12K	Sell	53,109 -5,868	-10%	-$4.73K	﹤0.01%	4615
2022 Q1	$45K	Buy	58,977 +29,538	+100%	+$21.6K	﹤0.01%	4542
2021 Q4	$35K	Hold	29,439	–	–	﹤0.01%	4777
2021 Q3	$30K	Buy	+29,439	New	+$30.9K	﹤0.01%	4780

Walleye Trading's GRNAW Position: Q3 2023 in Review

Walleye Trading sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 62,973 shares — an estimated $838 sold.

Walleye Trading first reported a position in GRNAW in Q3 2021 and held it in 8 quarters. The position peaked at $45K in Q1 2022. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Walleye Trading reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Walleye Trading sold 62,973 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $838.
Walleye Trading first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 8 quarters.
Walleye Trading's GreenLight Biosciences Holdings, PBC Warrant position peaked at $45K in Q1 2022.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Walleye Trading's 13F filing for Q3 2023, filed 14 Nov 2023.